Cosmax vs Kolmar: Which Korean ODM Fits Your Indie Brand?
Cosmax is the larger pure-cosmetics ODM with production across seven countries and a trend-led R&D pipeline that moves fastest on novel actives. Kolmar Korea is the only Korean ODM with scaled US manufacturing (300 million units across two Pennsylvania plants), making it the stronger tariff hedge for US-retail launches. Neither accepts direct orders below 5,000 units. Indie founders at 3,000 units need a Korean broker or should start with a boutique ODM and graduate to tier-one at scale.
• Cosmax posted record Q2 2026 revenue of KRW 794.9 billion (up 27%), with production across seven countries including a new Italian facility. Best fit for multi-region launches and trend-led ingredient innovation.
• Kolmar Korea posted record Q2 2026 operating profit of KRW 110.3 billion (up 50%). Two US plants produce 300 million units per year, making it the top choice for US-retail-first founders seeking tariff protection.
• Per-unit cost at 5,000 MOQ for a standard 50 ml skincare SKU: Cosmax runs $2.80 to $3.90; Kolmar runs $2.60 to $3.70, a 5 to 10% Kolmar advantage on skincare. Cosmax closes the gap on color cosmetics.
• Both ODMs quote 90 to 130 days from PO to ship with a locked formula. Add 30 to 60 days if you are still in sample-to-formula or packaging tooling.
• Founders launching under 5,000 units with no Korean intermediary should consider a boutique ODM at 1,000-unit MOQ first, then graduate to tier-one at scale.
The 2026 Landscape: Three Structural Shifts
Every indie founder sourcing from Korea lands on this question eventually. Cosmax or Kolmar? The two companies manufacture for a huge share of what you see at Sephora, Ulta, Olive Young, and Watsons. At indie scale, a wrong ODM match costs you six months minimum and a production run that does not fit your regulatory or tariff profile.
Three structural shifts make this comparison different from twelve months ago. First, US tariff policy on Korea-origin cosmetics pushed both companies to invest in local production on very different timelines. Kolmar completed its second US factory in Scott Township, Pennsylvania in July 2025, creating a combined 300 million unit annual capacity across two American plants. Cosmax operates a single US plant in New Jersey that turned profitable for the first time in Q2 2026 (revenue up 79% to KRW 53.8 billion) but lacks Kolmar's scale.
Second, Kolmar Korea was designated by the Korea Fair Trade Commission as a large business group in April 2026, the first cosmetics ODM to cross that threshold. The group now includes HK Inno.N (biohealth) and Yonwoo (packaging), giving Kolmar vertical packaging capability that indie founders can tap.
Third, Cosmax expanded globally by acquiring a 51% stake in Italian ODM Keminova in February 2026, adding a European production base. Production now spans seven countries: Korea, US, China, Indonesia, Thailand, Japan, and Italy. For founders planning to sell in the EU, this is a material change.
How Do Cosmax and Kolmar Compare on R&D Philosophy?
Cosmax is the largest pure-cosmetics ODM in Korea by revenue. The cosmetics segment posted KRW 2.166 trillion in 2025. Cosmax's strength is its trend-driven formulation approach: the company tends to lead Korean ODMs on commercializing novel actives like PDRN, exosomes, and spicule delivery systems. A founder launching simultaneously in the US, Europe, and Southeast Asia can source from a single ODM partner and shift production across borders if tariffs or supply disruptions hit one origin. The weakness is access: first-time founders without a Korean intermediary often wait weeks for sample timelines that a smaller ODM would turn around in days.
Kolmar Korea is the oldest cosmetics ODM in the country, founded in 1990. H1 2026 revenue climbed 14.8% to KRW 1.59 trillion, with operating profit surging 41.8% to KRW 189.2 billion. Kolmar's formulation reputation leans science-led rather than trend-led, with deep history in MFDS-recognized functional categories: whitening, anti-wrinkle, sun protection, hair growth, and dental functional cosmetics. Founders prioritizing clinical substantiation and regulatory dossier experience often find Kolmar's track record more reassuring. The weakness is overseas reach outside North America: Cosmax's China and Southeast Asian operations have grown faster, and Kolmar lacks a European production base.
Side-by-Side: What Indie Quotes Look Like
The numbers below reflect patterns from approximately 34 indie-stage quotes received from Cosmax, Kolmar, and their intermediary partners over the past 14 months. Individual quotes vary by formulation complexity, packaging tooling, regulatory scope, and season.
| Category | Cosmax | Kolmar Korea |
|---|---|---|
| Sample fees per round | $300 to $600 | $300 to $700 |
| Formulation fee per SKU | $5,000 to $9,500 | $4,500 to $8,500 |
| Per-unit cost (50 ml, 5K MOQ) | $2.80 to $3.90 | $2.60 to $3.70 |
| Multi-SKU discount | 18% to 28% (3 to 5 SKUs) | 18% to 28% (3 to 5 SKUs) |
| Lead time (PO to ship) | 90 to 130 days | 90 to 130 days |
| Direct MOQ | 5,000 to 10,000 units | 5,000 to 10,000 units |
| US production | 1 plant (NJ), newly profitable | 2 plants (PA), 300M units/yr |
The 5 to 10% Kolmar advantage on skincare reflects Yonwoo packaging integration and formulation efficiency on stability-tight formulas. Cosmax closes or reverses the gap on color cosmetics and complex functional categories where its R&D pipeline carries more proprietary IP.
Which ODM Fits Your Launch Scenario?
US retail with tariff protection: Kolmar wins. The Pennsylvania plants produce skincare, suncare, and color on US soil, sidestepping Korea-origin tariff exposure entirely. Cosmax's New Jersey plant exists but cannot match the product-line breadth or volume.
Multi-region launch with ingredient innovation: Cosmax wins. Seven-country production footprint plus a trend-led R&D pipeline that moves faster on novel actives. The Keminova acquisition adds European manufacturing for EU-bound products without a separate ODM relationship.
MFDS functional cosmetics: Both are strong, with different strengths. Kolmar has deeper history with functional notification dossiers and stability testing protocols. Cosmax moves faster on trend-led ingredients. Choose based on whether your brief prioritizes regulatory depth or speed to market.
First launch under 5,000 units: Neither is the right direct call. The realistic path is a Korean broker who aggregates your volume into a tier-one production slot (effective MOQ around 3,000 units), or a boutique ODM at 1,000 to 1,500 units where you build your formula, then graduate to tier-one at your second production run. For a detailed breakdown of per-unit economics at each MOQ tier, see our import cost stack guide.
Red Flags in Any Tier-One Quote
Two patterns deserve scrutiny regardless of which ODM you choose. First, raw material sourcing transparency. Both Cosmax and Kolmar should provide INCI documentation, raw material lot numbers, and master formula version history. If a quote sheet is thin on these specifics, request them in writing before signing a letter of intent.
Second, regulatory responsibility clarity. A founder going to market in the US, EU, and Korea simultaneously needs explicit written assignment of who prepares each regulatory dossier: MFDS notification, FDA MOCRA Responsible Person letter, EU CPNP, and UK SCPN. Both ODMs have the regulatory capacity, but neither will handle the full multi-market package by default at indie scale. The pricing is real and the scope needs to be in the PO. For the four specific timeline gotchas that catch most founders between PO and first shipment, see our ODM launch timeline guide.
"Still figuring out which Korean ODM fits your launch? The answer depends on your target market, your volume, your regulatory requirements, and your timeline. Both Cosmax and Kolmar are excellent manufacturers. The question is which one matches your specific scenario. Grab 15 free minutes with me and we will walk through the match."
Liz Song, K-beauty sourcing consultant | Bridging Korean ODMs and US indie brands
ALTA MEET helps indie founders match with the right Korean ODM for their category, volume, market list, and regulatory requirements. The ODM decision shapes your cost structure, timeline, and tariff exposure for the entire first production run.
Book a free 15-minute ODM match review with Liz
FAQ
Can an indie founder order directly from Cosmax or Kolmar at 3,000 units?
Not directly. Both ODMs quote 5,000 to 10,000 unit minimums for direct accounts. The 3,000-unit floor is accessed through Korean brokers or trading houses that aggregate indie volume into a production slot. First-time founders without an existing relationship typically need an intermediary or should start with a boutique ODM.
Which ODM is better for sunscreen and sun care products?
Both are strong in sunscreen formulation, but Kolmar now has a dedicated US suncare production line at its second Pennsylvania factory. For founders selling sunscreen primarily in the US market, Kolmar's ability to manufacture on US soil avoids Korea-origin tariff exposure and simplifies FDA OTC monograph compliance.
How long does production take from PO to shipment?
Both Cosmax and Kolmar quote 90 to 130 days from PO to shipment, assuming a locked master formula and finalized packaging spec. If you are still in the sample-to-formula or packaging tooling phase, add 30 to 60 days upfront. Q4 lead times tend to stretch an additional two to four weeks as both ODMs prioritize their larger brand accounts.
What is the per-unit cost difference between Cosmax and Kolmar for indie orders?
For a standard 50 ml skincare cream at 5,000-unit MOQ, observed quotes over the past 14 months landed at $2.80 to $3.90 per unit at Cosmax and $2.60 to $3.70 per unit at Kolmar Korea. Kolmar tends to run 5 to 10% lower on skincare, partly due to Yonwoo packaging integration. Cosmax closes the gap on color cosmetics and complex functional formulations.
By Liz Song, K-beauty sourcing consultant | Bridging Korean ODMs and US indie brands
Reviewed for accuracy by ALTA MEET's formulation consulting team. Sources: Cosmax Inc. Q2 2026 earnings (DART filings), Kolmar Korea Q2 2026 earnings (DART filings), Korea Customs Service Q1 2026 export data, KFTC large business group designation April 2026. Modernization of Cosmetics Regulation Act of 2022 (Public Law 117-328). EU Regulation 1223/2009.
